AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.
Go back to AMGEN MAKES REPATHA® AVAILABLE THROUGH AMGENNOW, A DIRECT-TO-PATIENT PROGRAM IN THE U.S.| Amgen Inc (NASDAQ: AMGN) | Delayed: 431.85 -5.14 (1.18%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $436.99 | 52 Week High | $176.85 | |||
| Open | $437.89 | 52 Week Low | $133.64 | |||
| Day High | $437.89 | P/E | 65.04 | |||
| Day Low | $430.72 | EPS | $6.64 | |||
| Volume | 987,141 | |||||
